Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice

Abstract Background Sodium glucose co-transporter2 inhibitors reduce the incidence of cardiovascular events in patients with type 2 diabetes mellitus based on the results of recent cardiovascular outcome studies. Herein, we investigated the effects of long-term treatment with canagliflozin on bioche...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Νarjes Nasiri-Ansari, Georgios K. Dimitriadis, Georgios Agrogiannis, Despoina Perrea, Ioannis D. Kostakis, Gregory Kaltsas, Athanasios G. Papavassiliou, Harpal S. Randeva, Eva Kassi
Format: Artigo
Sprog:Inglês
Udgivet: BMC 2018-07-01
Serier:Cardiovascular Diabetology
Fag:
Canagliflozin
SGLT2i
Atherosclerosis
Inflammation
APOE knockout mice
Online adgang:http://link.springer.com/article/10.1186/s12933-018-0749-1
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker